Abstract

Several studies have been conducted to evaluate the efficacy of statins in Korean and Asian patients. However, most previous studies only observed the percent reduction in low-density lipoprotein cholesterol (LDL-C) and did not consider the effects of various patient conditions simultaneously, such as abnormal test results, patient demographics, and prescribed drugs before taking a statin. Moreover, the characteristics of the patients whose percent reduction in LDL-C was higher than expected were not provided. Therefore, in this study, we aimed to derive meaningful phenotypes by using tensor factorization to observe the characteristics of the patients whose percent reduction in LDL-C was higher than expected among patients taking moderate-intensity statins. In addition, we used the derived phenotypes to predict how much the LDL-C levels of new patients decreased. We consequently identified eight phenotypes that represented the characteristics of the patients whose percent reduction in LDL-C was higher than expected. Moreover, the latent representations of the derived phenotypes achieved prediction performance similar to that obtained using the raw data. These results demonstrate that the derived phenotypes and latent representations are useful tools for observing the characteristics of patients and predicting LDL-C levels. Additionally, our findings provide direction on how to conduct clinical studies in the future.

Highlights

  • One of the important factors for arteriosclerosis is low-density lipoprotein cholesterol (LDL-C) [1]

  • For new patients with moderate-intensity statins, we predicted whether their percent reduction in LDL-C was higher than expected

  • Our results indicated that rosuvastatin (10 mg) is able to sufficiently reduce LDL-C levels and replace high-intensity statin therapy in Korean patients over the age of 40 with diabetes

Read more

Summary

Introduction

One of the important factors for arteriosclerosis is low-density lipoprotein cholesterol (LDL-C) [1]. High LDL-C levels can increase the probability of developing cardiovascular diseases (CVDs), such as ischaemic heart diseases [2]. For this reason, patients are prescribed statins to reduce their LDL-C levels and help prevent CVDs [3,4,5]. Doctors can prescribe patients various statins with different dosages. The expected efficacy of statins depends on the types and dosages of the statins; statins should be prescribed considering the target achievement rate. The most widely used statin guideline is the ACC/

Objectives
Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call